Sidebar: Antibiotics: The Triumph Of Hope Over Experience?
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Johnson & Johnson's swift exit from its collaboration with Basilea for Zevtera (ceftobiprole) is only the latest setback for the antibacterial field, which has had little success in producing NME approvals in recent years.